Science

Science, technology and the emergence of AI have converged to make precision medicine for acute care a reality. This is how we deliver healthcare tailored to biology.

Research & Development

Evidence

Clinical Trials

The Sepsis ImmunoScore® Predicts Sepsis, Mortality, and Deterioration Better than Clinical Scores and Widely Available Biomarkers

Read More →

Products

Prenosis is developing a pipeline of integrated diagnostics and therapeutics grounded in each patient's unique biological profile, using deep data science and AI to give clinicians tools that reflect the true complexity of critical disease.

Immunix®

Sepsis ImmunoScore®

BioAegis Therapeutics Announces Collaboration with Prenosis to Advance AI-Driven Precision Medicine in Inflammatory Disease

Read More →

Resources

Blogs, articles, videos, and podcasts exploring how precision medicine and AI are changing the way clinicians detect and treat critical conditions.

Resource Library

Events

Treating the Patient, Not the Disease

Read More →

Newsroom

Read the latest Prenosis peer-reviewed articles and items from scholarly journals.

Newsroom

Sepsis ImmunoScore Outperforms Conventional Sepsis Tools

Read More →

About

As a biology-based technology company, we combine data science with AI to transform how critical conditions are diagnosed and treated.

Mission, Vision & Values

Careers

Leadership

Awards

LifeBridge Health deploys Prenosis’ FDA-authorized AI tool to speed sepsis detection

Read More →

The Virtual Shift: Sepsis Awareness Month with Bobby Reddy, Jr., PhD

Healthcare NOW Radio | The Virtual Shift | September 14 Episode

Interview originally published on Healthcare NOW Radio September 14, 2025

Join The Virtual Shift host Tom Foley as he speaks with Prenosis CEO Bobby Reddy Jr., PhD, about revolutionizing sepsis care through precision diagnostics. In recognition of Sepsis Awareness Month, Bobby discusses Prenosis’ groundbreaking Sepsis ImmunoScore™—the first and only FDA-authorized AI tool for sepsis diagnosis and prediction.

The interview explores three key themes:

  • Delivering healthcare tailored to individual biology
  • Building effective clinician-AI partnerships that enhance trust and clinical decision-making
  • Navigating the complex FDA authorization process for innovative AI diagnostic tools.

Discover how artificial intelligence is transforming acute care delivery and ushering in a new era of precision medicine.

Listen to the interview >